世界の全身麻酔薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global General Anaesthesia Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12293 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、全身麻酔薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。全身麻酔薬の種類別市場規模（プロポフォール、セボフルラン、イソフルラン、デクスメデトミジン、デスフルラン、レミフェンタニル、ミダゾラム、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・全身麻酔薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Baxter International、AstraZeneca、Abbott Laboratories、Roche、Fresenius、Mylan、Eisai、Hospira、Hikma Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プロポフォール、セボフルラン、イソフルラン、デクスメデトミジン、デスフルラン、レミフェンタニル、ミダゾラム、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・全身麻酔薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・全身麻酔薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・全身麻酔薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・全身麻酔薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・全身麻酔薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The General Anaesthesia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global General Anaesthesia Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global General Anaesthesia Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
General Anaesthesia Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Propofol
Sevoflurane
Isoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
Others

Market segment by Application, can be divided into
Hospitals
Clinics
Others

Market segment by players, this report covers
Baxter International
AstraZeneca
Abbott Laboratories
Roche
Fresenius
Mylan
Eisai
Hospira
Hikma Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of General Anaesthesia Drugs
1.2 Classification of General Anaesthesia Drugs by Type
1.2.1 Overview: Global General Anaesthesia Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global General Anaesthesia Drugs Revenue Market Share by Type in 2020
1.2.3 Propofol
1.2.4 Sevoflurane
1.2.5 Isoflurane
1.2.6 Dexmedetomidine
1.2.7 Desflurane
1.2.8 Remifentanil
1.2.9 Midazolam
1.2.10 Others
1.3 Global General Anaesthesia Drugs Market by Application
1.3.1 Overview: Global General Anaesthesia Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global General Anaesthesia Drugs Market Size & Forecast
1.5 Global General Anaesthesia Drugs Market Size and Forecast by Region
1.5.1 Global General Anaesthesia Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global General Anaesthesia Drugs Market Size by Region, (2016-2021)
1.5.3 North America General Anaesthesia Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe General Anaesthesia Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific General Anaesthesia Drugs Market Size and Prospect (2016-2026)
1.5.6 South America General Anaesthesia Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa General Anaesthesia Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 General Anaesthesia Drugs Market Drivers
1.6.2 General Anaesthesia Drugs Market Restraints
1.6.3 General Anaesthesia Drugs Trends Analysis
2 Company Profiles
2.1 Baxter International
2.1.1 Baxter International Details
2.1.2 Baxter International Major Business
2.1.3 Baxter International General Anaesthesia Drugs Product and Solutions
2.1.4 Baxter International General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Baxter International Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca General Anaesthesia Drugs Product and Solutions
2.2.4 AstraZeneca General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories General Anaesthesia Drugs Product and Solutions
2.3.4 Abbott Laboratories General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche General Anaesthesia Drugs Product and Solutions
2.4.4 Roche General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Fresenius
2.5.1 Fresenius Details
2.5.2 Fresenius Major Business
2.5.3 Fresenius General Anaesthesia Drugs Product and Solutions
2.5.4 Fresenius General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Fresenius Recent Developments and Future Plans
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan General Anaesthesia Drugs Product and Solutions
2.6.4 Mylan General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Mylan Recent Developments and Future Plans
2.7 Eisai
2.7.1 Eisai Details
2.7.2 Eisai Major Business
2.7.3 Eisai General Anaesthesia Drugs Product and Solutions
2.7.4 Eisai General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Eisai Recent Developments and Future Plans
2.8 Hospira
2.8.1 Hospira Details
2.8.2 Hospira Major Business
2.8.3 Hospira General Anaesthesia Drugs Product and Solutions
2.8.4 Hospira General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Hospira Recent Developments and Future Plans
2.9 Hikma Pharmaceuticals
2.9.1 Hikma Pharmaceuticals Details
2.9.2 Hikma Pharmaceuticals Major Business
2.9.3 Hikma Pharmaceuticals General Anaesthesia Drugs Product and Solutions
2.9.4 Hikma Pharmaceuticals General Anaesthesia Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Hikma Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global General Anaesthesia Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 General Anaesthesia Drugs Players Market Share
3.2.2 Top 10 General Anaesthesia Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 General Anaesthesia Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global General Anaesthesia Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global General Anaesthesia Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global General Anaesthesia Drugs Revenue Market Share by Application (2016-2021)
5.2 General Anaesthesia Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America General Anaesthesia Drugs Revenue by Type (2016-2026)
6.2 North America General Anaesthesia Drugs Revenue by Application (2016-2026)
6.3 North America General Anaesthesia Drugs Market Size by Country
6.3.1 North America General Anaesthesia Drugs Revenue by Country (2016-2026)
6.3.2 United States General Anaesthesia Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada General Anaesthesia Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico General Anaesthesia Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe General Anaesthesia Drugs Revenue by Type (2016-2026)
7.2 Europe General Anaesthesia Drugs Revenue by Application (2016-2026)
7.3 Europe General Anaesthesia Drugs Market Size by Country
7.3.1 Europe General Anaesthesia Drugs Revenue by Country (2016-2026)
7.3.2 Germany General Anaesthesia Drugs Market Size and Forecast (2016-2026)
7.3.3 France General Anaesthesia Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom General Anaesthesia Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia General Anaesthesia Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy General Anaesthesia Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific General Anaesthesia Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific General Anaesthesia Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific General Anaesthesia Drugs Market Size by Region
8.3.1 Asia-Pacific General Anaesthesia Drugs Revenue by Region (2016-2026)
8.3.2 China General Anaesthesia Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan General Anaesthesia Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea General Anaesthesia Drugs Market Size and Forecast (2016-2026)
8.3.5 India General Anaesthesia Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia General Anaesthesia Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia General Anaesthesia Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America General Anaesthesia Drugs Revenue by Type (2016-2026)
9.2 South America General Anaesthesia Drugs Revenue by Application (2016-2026)
9.3 South America General Anaesthesia Drugs Market Size by Country
9.3.1 South America General Anaesthesia Drugs Revenue by Country (2016-2026)
9.3.2 Brazil General Anaesthesia Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina General Anaesthesia Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa General Anaesthesia Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa General Anaesthesia Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa General Anaesthesia Drugs Market Size by Country
10.3.1 Middle East & Africa General Anaesthesia Drugs Revenue by Country (2016-2026)
10.3.2 Turkey General Anaesthesia Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia General Anaesthesia Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE General Anaesthesia Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global General Anaesthesia Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global General Anaesthesia Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market General Anaesthesia Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global General Anaesthesia Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global General Anaesthesia Drugs Revenue Market Share by Region (2021-2026)
Table 6. Baxter International Corporate Information, Head Office, and Major Competitors
Table 7. Baxter International Major Business
Table 8. Baxter International General Anaesthesia Drugs Product and Solutions
Table 9. Baxter International General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca General Anaesthesia Drugs Product and Solutions
Table 13. AstraZeneca General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories General Anaesthesia Drugs Product and Solutions
Table 17. Abbott Laboratories General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche General Anaesthesia Drugs Product and Solutions
Table 21. Roche General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Fresenius Corporate Information, Head Office, and Major Competitors
Table 23. Fresenius Major Business
Table 24. Fresenius General Anaesthesia Drugs Product and Solutions
Table 25. Fresenius General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Mylan Corporate Information, Head Office, and Major Competitors
Table 27. Mylan Major Business
Table 28. Mylan General Anaesthesia Drugs Product and Solutions
Table 29. Mylan General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Eisai Corporate Information, Head Office, and Major Competitors
Table 31. Eisai Major Business
Table 32. Eisai General Anaesthesia Drugs Product and Solutions
Table 33. Eisai General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Hospira Corporate Information, Head Office, and Major Competitors
Table 35. Hospira Major Business
Table 36. Hospira General Anaesthesia Drugs Product and Solutions
Table 37. Hospira General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Hikma Pharmaceuticals Major Business
Table 40. Hikma Pharmaceuticals General Anaesthesia Drugs Product and Solutions
Table 41. Hikma Pharmaceuticals General Anaesthesia Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global General Anaesthesia Drugs Revenue (USD Million) by Players (2019-2021)
Table 43. Global General Anaesthesia Drugs Revenue Share by Players (2019-2021)
Table 44. Breakdown of General Anaesthesia Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. General Anaesthesia Drugs Players Head Office, Products and Services Provided
Table 46. General Anaesthesia Drugs Mergers & Acquisitions in the Past Five Years
Table 47. General Anaesthesia Drugs New Entrants and Expansion Plans
Table 48. Global General Anaesthesia Drugs Revenue (USD Million) by Type (2016-2021)
Table 49. Global General Anaesthesia Drugs Revenue Share by Type (2016-2021)
Table 50. Global General Anaesthesia Drugs Revenue Forecast by Type (2021-2026)
Table 51. Global General Anaesthesia Drugs Revenue by Application (2016-2021)
Table 52. Global General Anaesthesia Drugs Revenue Forecast by Application (2021-2026)
Table 53. North America General Anaesthesia Drugs Revenue by Type (2016-2021) & (USD Million)
Table 54. North America General Anaesthesia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 55. North America General Anaesthesia Drugs Revenue by Application (2016-2021) & (USD Million)
Table 56. North America General Anaesthesia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 57. North America General Anaesthesia Drugs Revenue by Country (2016-2021) & (USD Million)
Table 58. North America General Anaesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe General Anaesthesia Drugs Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe General Anaesthesia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe General Anaesthesia Drugs Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe General Anaesthesia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe General Anaesthesia Drugs Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe General Anaesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific General Anaesthesia Drugs Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific General Anaesthesia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific General Anaesthesia Drugs Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific General Anaesthesia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific General Anaesthesia Drugs Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific General Anaesthesia Drugs Revenue by Region (2021-2026) & (USD Million)
Table 71. South America General Anaesthesia Drugs Revenue by Type (2016-2021) & (USD Million)
Table 72. South America General Anaesthesia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 73. South America General Anaesthesia Drugs Revenue by Application (2016-2021) & (USD Million)
Table 74. South America General Anaesthesia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 75. South America General Anaesthesia Drugs Revenue by Country (2016-2021) & (USD Million)
Table 76. South America General Anaesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa General Anaesthesia Drugs Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa General Anaesthesia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa General Anaesthesia Drugs Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa General Anaesthesia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa General Anaesthesia Drugs Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa General Anaesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. General Anaesthesia Drugs Picture
Figure 2. Global General Anaesthesia Drugs Revenue Market Share by Type in 2020
Figure 3. Propofol
Figure 4. Sevoflurane
Figure 5. Isoflurane
Figure 6. Dexmedetomidine
Figure 7. Desflurane
Figure 8. Remifentanil
Figure 9. Midazolam
Figure 10. Others
Figure 11. General Anaesthesia Drugs Revenue Market Share by Application in 2020
Figure 12. Hospitals Picture
Figure 13. Clinics Picture
Figure 14. Others Picture
Figure 15. Global General Anaesthesia Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global General Anaesthesia Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global General Anaesthesia Drugs Revenue Market Share by Region (2016-2026)
Figure 18. Global General Anaesthesia Drugs Revenue Market Share by Region in 2020
Figure 19. North America General Anaesthesia Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe General Anaesthesia Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific General Anaesthesia Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America General Anaesthesia Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Middle East and Africa General Anaesthesia Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. General Anaesthesia Drugs Market Drivers
Figure 25. General Anaesthesia Drugs Market Restraints
Figure 26. General Anaesthesia Drugs Market Trends
Figure 27. Baxter International Recent Developments and Future Plans
Figure 28. AstraZeneca Recent Developments and Future Plans
Figure 29. Abbott Laboratories Recent Developments and Future Plans
Figure 30. Roche Recent Developments and Future Plans
Figure 31. Fresenius Recent Developments and Future Plans
Figure 32. Mylan Recent Developments and Future Plans
Figure 33. Eisai Recent Developments and Future Plans
Figure 34. Hospira Recent Developments and Future Plans
Figure 35. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 36. Global General Anaesthesia Drugs Revenue Share by Players in 2020
Figure 37. General Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players General Anaesthesia Drugs Revenue Market Share in 2020
Figure 39. Global Top 10 Players General Anaesthesia Drugs Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global General Anaesthesia Drugs Revenue Share by Type in 2020
Figure 42. Global General Anaesthesia Drugs Market Share Forecast by Type (2021-2026)
Figure 43. Global General Anaesthesia Drugs Revenue Share by Application in 2020
Figure 44. Global General Anaesthesia Drugs Market Share Forecast by Application (2021-2026)
Figure 45. North America General Anaesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 46. North America General Anaesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 47. North America General Anaesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 48. United States General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe General Anaesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 52. Europe General Anaesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 53. Europe General Anaesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 54. Germany General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific General Anaesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific General Anaesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific General Anaesthesia Drugs Revenue Market Share by Region (2016-2026)
Figure 62. China General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America General Anaesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America General Anaesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America General Anaesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Brazil General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa General Anaesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa General Anaesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa General Anaesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Turkey General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE General Anaesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source

---